[1]
Parimi, S., Bondy, S., Tsang, E., McKenzie, M.R., Bachand, F., Aparicio, M., Duncan, G., Sunderland, K., Olson, R.A., Pai, H.H., Alexander, A.S., LaPointe, V., Chi, K.N. and Tyldesley, S. 2018. Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer. Canadian Urological Association Journal. 13, 10 (Dec. 2018), E311-6. DOI:https://doi.org/10.5489/cuaj.5685.